Immunogenicity and safety of a proposed pegfilgrastim biosimilar MSB11455 versus the reference pegfilgrastim Neulasta

Wynne, Chris

Immunogenicity and safety of a proposed pegfilgrastim biosimilar MSB11455 versus the reference pegfilgrastim Neulasta [electronic resource] - Pharmacology research & perspectives 04 2020 - e00578 p. digital

Publication Type: Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't

2052-1707

10.1002/prp2.578 doi


Adult
Antibodies--blood
Biosimilar Pharmaceuticals--adverse effects
Double-Blind Method
Female
Filgrastim--adverse effects
Healthy Volunteers
Humans
Male
Polyethylene Glycols--adverse effects
Young Adult